Our Company
Intact Genomics (ig®) is a leading provider of unique products and advanced genomic services for DNA/RNA isothermal amplification for disease diagnostics, anti-fungal drug discovery, gene-editing, simplified molecular cloning, and large DNA fragment Cloning. We have dedicated scientists and state of the art equipment housed in a modern facility. Started in 2013 and located in a beautiful, safe, and quiet suburb of St. Louis, Missouri, close to Bayer Crop Science Headquarters, Donald Danforth Plant Science Center, and Washington University in St. Louis. The company has developed more than 100 products to support researchers and laboratories worldwide in their pursuit of groundbreaking advancements in life sciences.
We provide high-quality life science products including high-quality competent cells, robust enzymes/proteins, large insert DNA cloning, manipulation, and BAC library related services to help scientists explore the genome structure and function of microorganisms, plants and animal species. Our highly experienced team of scientists provide outstanding personalized services, fast turnaround times, and the most reasonable prices in the industry.
We also apply BAC related technologies in metagenomic research to develop new solutions for agricultural research, natural product-enzyme discovery, and environmental protection. At Intact Genomics Inc, our experts are the world-class leaders of high molecular weight (HMW) genomic DNA preparation, large DNA fragment manipulation, unbiased bacterial artificial chromosome (BAC) library construction, protein expression and purification. We continuously focus on genomic technology innovation.
Our History
Intact Genomics, Inc. was founded by Dr. Chengcang Charles Wu, an accomplished scientist and business executive with extensive experience in technology development and the early commercialization of biotechnology innovations. Prior to founding Intact Genomics, Dr. Wu served as the founding Vice President of Genome Technology Development and Custom Services at Lucigen Corporation, which was acquired by LGC Biosearch Technologies in 2018. During his tenure at Lucigen, he developed innovative products and technologies and made significant contributions to transforming the company from a biotech startup into a leading manufacturer of molecular biology products.
Dr. Wu is a world-renowned expert in large-fragment DNA cloning and BAC library technologies. He is the inventor of Fungal Artificial Chromosomes (FAC), a major contributor to the first soybean physical map, and one of the leading inventors of plant artificial chromosomes.
In 2013, Dr. Wu started Intact Genomics in St. Louis, Missouri, USA with his wife and long-time collaborator, Rosa Ye, to pursue their shared curiosity and passion for life sciences. Today, Intact Genomics is supported by a diverse team of experienced professionals, united by a common purpose and a strong commitment to serving customers and the global life science community.
Our Mission
We are dedicated to science and discovering solutions to the grand challenges in human health, agriculture and environment.
Our Vision
We provide advanced research tools for life science and develop new technologies for drug discovery from soil and other environmental microorganisms.
Our Values and Culture
Innovation: We develop innovative products and technologies that improve human health, agriculture, and the environment. Our commitment to innovation ensures we stay ahead in a rapidly evolving market.
Customer Focus: Our customers are at the heart of everything we do. We listen to their needs, anticipate their expectations, and deliver solutions that exceed their expectations, ensuring their success and satisfaction.
Integrity: We conduct business ethically, and authentically in all our professional interactions. Integrity is the cornerstone of our relationships with customers, partners, and employees, building trust and credibility.
Determination: We are driven by a relentless pursuit of excellence. Our determination fuels our resilience and perseverance, enabling us to overcome challenges and achieve our goals.
Growth: We are committed to continuous improvement and development. As individuals, we embrace professional growth. As a company, we pursue new opportunities to make a significant impact on life sciences and continue to grow our business.
ISO 13485 Certified
Intact Genomics received ISO 13485:2016 certification in August 2023.
Minority Business Enterprise (MBE)
Intact Genomics qualifies as a Minority-Owned Business Enterprise and is certified by the State of Missouri, USA.
Minority Business Enterprise Certificate